{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:34:36Z","timestamp":1770060876224,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.4158\/ep-2018-0392","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T18:16:45Z","timestamp":1555525005000},"page":"340-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Management and Outcomes of Giant Prolactinoma: A Series of 71 Patients"],"prefix":"10.1016","volume":"25","author":[{"given":"O ksana","family":"Hamidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Van Gompel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucinda","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana Esi","family":"Kittah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Donegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Philbrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly K.","family":"Koeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Natt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd B.","family":"Nippoldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"William F.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2018-0392_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"key":"10.4158\/EP-2018-0392_bb0015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(98)03356-X","article-title":"Growth-hormone and prolactin excess","volume":"352","author":"Colao","year":"1998","journal-title":"Lancet"},{"key":"10.4158\/EP-2018-0392_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","article-title":"Giant prolactinomas: clinical management and long-term follow up","volume":"97","author":"Shrivastava","year":"2002","journal-title":"J Neurosurg"},{"key":"10.4158\/EP-2018-0392_bb0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2265.2003.01770.x","article-title":"Giant prolactinomas in men: efficacy of cabergoline treatment","volume":"58","author":"Corsello","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0392_bb0030","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1530\/EJE-14-0013","article-title":"Therapy of endocrine disease: the challenges in managing giant prolactinomas","volume":"170","author":"Maiter","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0392_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"key":"10.4158\/EP-2018-0392_bb0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/a-0752-0741","article-title":"Giant prolactinoma in men: clinical features and therapeutic outcomes","volume":"50","author":"Iglesias","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.4158\/EP-2018-0392_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-13-0503","article-title":"Giant prolactinomas in women","volume":"170","author":"Delgrange","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0392_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11102-014-0588-3","article-title":"Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases","volume":"18","author":"Almalki","year":"2015","journal-title":"Pituitary"},{"key":"10.4158\/EP-2018-0392_bb0055","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.4158\/EP-2018-0392_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/neurosurgery\/16.CN_suppl_1.185","article-title":"Transphenoidal microsurgery of the normal and pathological pituitary","volume":"16","author":"Hardy","year":"1969","journal-title":"Neurosurgery"},{"key":"10.4158\/EP-2018-0392_bb0065","article-title":"Giant prolactinomas: outcomes of multi-modal treatments for 42 cases with long-term follow-up","author":"Lv","year":"2018","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.4158\/EP-2018-0392_bb0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"10.4158\/EP-2018-0392_bb0075","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0002-9343(87)90668-1","article-title":"Giant invasive prolactinomas","volume":"83","author":"Murphy","year":"1987","journal-title":"Am J Med"},{"key":"10.4158\/EP-2018-0392_bb0080","first-page":"227","article-title":"Giant invasive prolactinoma: a case report and review of nine further cases","volume":"74","author":"Davis","year":"1990","journal-title":"Q J Med"},{"key":"10.4158\/EP-2018-0392_bb0085","first-page":"129","article-title":"Treatment of extensively invasive (giant) prolactinomas with bromocriptine","volume":"105","author":"Grebe","year":"1992","journal-title":"N Z Med J"},{"key":"10.4158\/EP-2018-0392_bb0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1507\/endocrj.45.529","article-title":"Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment","volume":"45","author":"Saeki","year":"1998","journal-title":"Endocr J"},{"key":"10.4158\/EP-2018-0392_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0090-3019(01)00697-8","article-title":"Giant prolactinomas presenting as skull base tumors","volume":"57","author":"Minniti","year":"2002","journal-title":"Surg Neurol"},{"key":"10.4158\/EP-2018-0392_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-06-0646","article-title":"Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men","volume":"156","author":"Shimon","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0392_bb0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2265.1985.tb02992.x","article-title":"Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report","volume":"22","author":"Clayton","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0392_bb0110","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2016-2008","article-title":"Dopamine agonists can reduce cystic prolactinomas","volume":"101","author":"Faje","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0392_bb0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0392_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3171\/jns.2006.104.1.54","article-title":"Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up","volume":"104","author":"Wu","year":"2006","journal-title":"J Neurosurg"},{"key":"10.4158\/EP-2018-0392_bb0125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3171\/2009.3.JNS0929","article-title":"Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases","volume":"112","author":"Zhao","year":"2010","journal-title":"J Neurosurg"},{"key":"10.4158\/EP-2018-0392_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/02688690903370305","article-title":"Giant pituitary adenomas--an enigma revisited. Microsurgical treatment strategies and outcome in a series of 250 patients","volume":"24","author":"Sinha","year":"2010","journal-title":"Br J Neurosurg"},{"key":"10.4158\/EP-2018-0392_bb0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11102-018-0898-y","article-title":"Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study","volume":"21","author":"Liu","year":"2018","journal-title":"Pituitary"},{"key":"10.4158\/EP-2018-0392_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01815445","article-title":"Giant pituitary adenomas","volume":"8","author":"Pia","year":"1985","journal-title":"Neurosurg Rev"},{"key":"10.4158\/EP-2018-0392_bb0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2265.1991.tb00312.x","article-title":"Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up","volume":"34","author":"Tsagarakis","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0392_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jocn.2002.11.002","article-title":"Treatments of multi-invasive giant prolactinoma","volume":"11","author":"Yang","year":"2004","journal-title":"J Clin Neurosci"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:06:39Z","timestamp":1761516399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20358651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1530891X20358651"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0392","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management and Outcomes of Giant Prolactinoma: A Series of 71 Patients","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}